EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Return to 2016 GA agenda page here.
European initiatives on the issue of medicines shortages are now taking place on several fronts. A challenge in the year ahead will be coordination and countering proposals for solution that are suboptimal to the hospital pharmacist perspective (e.g. use of restricted definitions).
COST Action
An application to the European “Cooperation in Science and Technology” (COST) programme to fund a research network on the issue of medicines shortages achieved success in Autumn 2015. The “Action” is led by Prof Helena Jenzer of the EAHP Scientific Committee, and held its first meeting in Brussels in April 2016. More information on the Action here. Membership of the Management Committee here.
It is intended that this collaboration of researchers and interest groups can yield progress on such issues as definitions of shortages, understanding of their impact, and recommendations as to policy solutions.
European Medicines Agency workstreams
In response to continued concerns being raised through healthcare professional and patient stakeholder organisations within its network, the European Medicines Agency held a second workshop on the issue of medicines shortages in October 2015. Arising from this event, EMA has committed itself to taking forward four workstreams:
More information here.
Collaboration with “Medicines Supply Chain Actors”
EAHP is participating in the creation of a ‘consensus paper’ on medicines shortages information system alongside the Pharmaceutical Group of the European Union (PGEU – representing community pharmacists), the European Federation of Pharmaceutical Industry Associations (EFPIA – representing the originator industry), Medicines for Europe (representing the generic manufacturers), the European Healthcare Distribution Association (wholesalers), the Association of the European Self-Medication Industry (AESGP – non prescription medicine manufacturers), the European Association of Euro-Pharmaceutical Companies (EAEPC – parallel traders), and the European Industrial Pharmacists Group (EIPG).
The intention is to set out some agreed principles by which medicines shortages information systems across Europe should operate to. e.g. fields of information, methods of reporting and verification of suspected shortages, levels of access, archiving of information etc. The agreement on these principles can then be used to develop information systems at the European and national level.
Throughout, EAHP is seeking to emphasise the need for open access systems, rejecting suggestions by others that open publication of shortages information creates panics.
Further progress on the initiative may be available to report by the time of the General Assembly.
EU Presidency developments and other
EAHP continues to work with partner organisations such as Eurordis (rare disease patients) to gain the attention of the EU Presidency to the topic of medicines shortages, and to provide the European Commission and European Medicines Agency with better mandate for action.
Some progress was made in this respect within the Luxembourg Presidency Council conclusions of July 2015, which recommended “the elaboration of appropriate monitoring instruments relating to medicines shortages, due to parallel export or other reasons”. More information here.
It is hoped further progress can be made on this recommendation under the Slovakia Presidency July 2016-December 2016.
EAHP continues to monitor and respond to international developments on the medicines shortages topic, such as those made by FIP and the World Health Organisation (WHO). More information here.
